1. Home
  2. CRON vs DNTH Comparison

CRON vs DNTH Comparison

Compare CRON & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRON
  • DNTH
  • Stock Information
  • Founded
  • CRON N/A
  • DNTH 2015
  • Country
  • CRON Canada
  • DNTH United States
  • Employees
  • CRON N/A
  • DNTH N/A
  • Industry
  • CRON Medicinal Chemicals and Botanical Products
  • DNTH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRON Health Care
  • DNTH Health Care
  • Exchange
  • CRON Nasdaq
  • DNTH Nasdaq
  • Market Cap
  • CRON 684.7M
  • DNTH 568.6M
  • IPO Year
  • CRON N/A
  • DNTH N/A
  • Fundamental
  • Price
  • CRON $1.90
  • DNTH $18.38
  • Analyst Decision
  • CRON
  • DNTH Strong Buy
  • Analyst Count
  • CRON 0
  • DNTH 8
  • Target Price
  • CRON N/A
  • DNTH $53.00
  • AVG Volume (30 Days)
  • CRON 1.4M
  • DNTH 281.8K
  • Earning Date
  • CRON 08-07-2025
  • DNTH 08-07-2025
  • Dividend Yield
  • CRON N/A
  • DNTH N/A
  • EPS Growth
  • CRON N/A
  • DNTH N/A
  • EPS
  • CRON 0.13
  • DNTH N/A
  • Revenue
  • CRON $124,589,000.00
  • DNTH $6,524,000.00
  • Revenue This Year
  • CRON $25.49
  • DNTH N/A
  • Revenue Next Year
  • CRON $7.45
  • DNTH N/A
  • P/E Ratio
  • CRON $14.77
  • DNTH N/A
  • Revenue Growth
  • CRON 33.92
  • DNTH 102.36
  • 52 Week Low
  • CRON $1.60
  • DNTH $13.37
  • 52 Week High
  • CRON $2.54
  • DNTH $32.27
  • Technical
  • Relative Strength Index (RSI)
  • CRON 46.71
  • DNTH 50.80
  • Support Level
  • CRON $1.87
  • DNTH $17.11
  • Resistance Level
  • CRON $1.93
  • DNTH $18.48
  • Average True Range (ATR)
  • CRON 0.05
  • DNTH 1.10
  • MACD
  • CRON -0.01
  • DNTH 0.08
  • Stochastic Oscillator
  • CRON 41.18
  • DNTH 59.86

About CRON Cronos Group Inc. Common Share

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: